Prem Watsa
Fairfax Financial Holdings
Fairfax Financial Holdings Portfolio 13F
Prem Watsa Holdings Activity
- Portfolio value:
- $1.84B≈ (+$288M≈)
- Previous value:
- $1.56B≈
- # of changes:
- 9
- New positions:
- 1
- Reported for:
- 31 Mar 2025 (Q1)
- Latest filing date:
- 15 May 2025
Fairfax Financial Holdings has disclosed a total of 9 changes to the portfolio in the (2025 Q1) SEC report(s): increased the number of shares of 3, bought 1 totally new, decreased the number of shares of 2 and completely sold out 3 position(s).
In the 2025 Q1 report(s) the following change has been made to the top investments: (CLF) Cleveland-Cliffs Inc (added shares +152.56%).
Warning: SEC insider reports detected for Fairfax Financial Holdings (real-time trades and ownership disclosures)
4 transactions as of 1 month ago
9 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lifeway Foods Inc
|
new
|
+17,367
|
17,367
|
+0.02%
|
$24.45
|
+25.56%($30.70)
|
0.02%
|
2025 Q1
|
≈ 0.25 years
|
|
|
|
Cleveland-Cliffs Inc
|
+152.56%
|
+9,000,000
|
14,899,273
|
+4.01%
|
$8.22
|
+40.39%($11.54)
|
6.64%
|
2024 Q4
|
≈ 0.50 years
|
|
|
|
Molson Coors Brewing Co, CL-B
|
+1.69%
|
+20,000
|
1,206,500
|
+0.07%
|
$60.89
|
-32.55%($41.07)
|
3.98%
|
2024 Q4
|
≈ 0.50 years
|
|
|
|
Kraft Heinz Co
|
+1.36%
|
+45,000
|
3,359,000
|
+0.07%
|
$30.42
|
|
5.54%
|
2024 Q3
|
≈ 0.75 years
|
|
|
|
Colliers International Group Inc Bats
|
-12.00%
|
-3,000
|
22,000
|
-0.02%
|
$117.77
|
-13.41%($101.98)
|
0.14%
|
2019 Q4
|
≈ 5.50 years
|
|
|
|
KKR & Co Inc
|
-14.89%
|
-3,500
|
20,000
|
-0.03%
|
$115.61
|
-12.59%($101.06)
|
0.13%
|
2019 Q4
|
≈ 5.50 years
|
|
|
|
Xeris Pharmaceuticals Inc
|
-100%
|
-139,687
|
0
|
-0.03%
|
$3.38
|
+147.63%($8.37)
|
0.00%
|
2021 Q4
|
≈ 3.25 years
|
|
|
|
TFI International Inc
|
-100%
|
-13,300
|
0
|
-0.11%
|
$134.40
|
+7.97%($145.12)
|
0.00%
|
2022 Q2
|
≈ 2.75 years
|
|
|
|
Revance Therapeutics, Inc
|
-100%
|
-21,158
|
0
|
-0%
|
$3.03
|
|
0.00%
|
2024 Q4
|
≈ 0.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.